News | May 11, 2024
Ami Organics posts Q4 FY24 consolidated profit at Rs. 25.14 Cr
Ami Organics has reported total income of Rs. 226.30 crores during the period ended March 31, 2024
Ami Organics has reported total income of Rs. 226.30 crores during the period ended March 31, 2024
The company is committed to address this observation comprehensively within stipulated time
the campaign emphasizes the brand's reliability and effectiveness in providing timely relief
Ashland's nutraceuticals business supplies a broad portfolio of active ingredients and formulation aids to nutritional product companies
First BTK inhibitor to show favourable trend in overall survival vs. standard-of-care chemoimmunotherapy in this setting
Wacker Biotech US, a wholly owned subsidiary of Wacker Chemie AG, specializes in the microbial production of pDNA
Investing in Malaysia's largest clinic operator to expand the healthcare business
Cellectis is also eligible to receive an investigational new drug (IND) option fee and development
With this, for all our USFDA facilities, EIRs are in place
Eugia Pharma Specialities receives 7 observations from USFDA for Unit II
Subscribe To Our Newsletter & Stay Updated
